Delivery Order SPE2DR25D3103-SPE2DR26F9Y07
- Not listed
- The Defense Logistics Agency awarded a $22,883.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sunitinib Malate 37.5 mg capsules (28-count packaging) on September 22, 2025, with completion targeted for September 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract vehicle,...
- The Defense Logistics Agency awarded a $35,205.19 delivery order to AmerisourceBergen Drug Corp for Sunitinib Malate 25 mg capsules (28-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed and shipped...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sunitinib Malate 50 mg capsules (28-count packages) with a ceiling value of $22,358.72. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $37,245.18 to AmerisourceBergen Drug Corp for the supply of Sunitinib Malate 25 mg capsules (28-count units). This competitively awarded contract, issued on September 25, 2025, with a completion date of September 26, 2025, represents a firm fixed price delivery order with no set-aside designation. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sunitinib Malate 37.5 mg capsules (28-count packages) under a firm fixed-price contract valued at $11,166.94. The delivery order was awarded on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This competitively awarded contract includes no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count units) with a ceiling value of $11,228.08. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract vehicle. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025, and...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $35,742.65 to AmerisourceBergen Drug Corp for the supply of Sunitinib Malate 50 mg capsules (28-count units). This firm fixed-price contract was competitively awarded without set-aside provisions and is scheduled for completion by September 16, 2025. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Sunitinib Malate is a targeted cancer therapy used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) with a ceiling value of $9,141.79. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Sunitinib Malate 50 mg capsules (quantity 28) with a ceiling value of $11,179.35. This firm fixed price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor agreement running through December 2026. The contract...
- This is a delivery order from the Defense Logistics Agency (DLA) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sunitinib Malate 25 mg capsules. The order, valued at $37,567.48, has a firm fixed price pricing type and an ultimate completion date of August 14, 2024. The contract does not have a set-aside designation. As a large pharmaceutical supplier, AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Y07Delivery Order
The Defense Logistics Agency awarded a $14,317.67 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 15, 2026, for the supply of Sunitinib Malate 25 mg capsules with a completion date of January 16, 2026. This is an unset-aside, competitively awarded contract with performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. Amerisourcebergen Drug Corp functions as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive contract portfolio with DLA demonstrates its capability to supply a broad range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This specific delivery order for Sunitinib Malate—an oncology medication—reflects the company's ongoing role in fulfilling essential pharmaceutical needs for the Department of Defense and allied federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 1/14/26 |